KCTD15 Antikörper (AA 1-234)
Kurzübersicht für KCTD15 Antikörper (AA 1-234) (ABIN528877)
Target
Alle KCTD15 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-234
-
Verwendungszweck
- Mouse polyclonal antibody raised against a full-length human KCTD15 protein.
-
Sequenz
- MPHRKERPSG SSLHTHGSTG TAEGGNMSRL SLTRSPVSPL AAQGIPLPAQ LTKSNAPVHI DVGSHMYTSS LATLTKYPDS RISRLFNGTE PIVLDSLKQH YFIDRDGEIF RYVLSFLRTS KLLLPDDFKD FSLLYEEARY YQLQPMVREL ERWQQEQEQR RRSRACDCLV VRVTPDLGER IALSGEKALI EEVFPETGDV MCNSVNAGWN QDPTHVIRFP LNGYCRLNSV QDVL
-
Kreuzreaktivität
- Human, Ratte
-
Produktmerkmale
- Antibody reactive against mammalian transfected lysate.
-
Immunogen
- KCTD15 (NP_076981.1, 1 a.a. ~ 234 a.a) full-length human protein.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
: "Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Issue 8, pp. 2870-5, (2013) (PubMed).
: "The BTB-containing protein Kctd15 is SUMOylated in vivo." in: PLoS ONE, Vol. 8, Issue 9, pp. e75016, (2013) (PubMed).
-
: "Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Issue 8, pp. 2870-5, (2013) (PubMed).
-
- KCTD15 (Potassium Channel Tetramerisation Domain Containing 15 (KCTD15))
-
Andere Bezeichnung
- KCTD15
-
Hintergrund
-
Full Gene Name: potassium channel tetramerisation domain containing 15
Synonyms: MGC25497,MGC2628 -
Gen-ID
- 79047
-
NCBI Accession
- NM_024076
Target
-